Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2016 Feb 4;36(4):743–749. doi: 10.1161/ATVBAHA.115.307043

Table 1.

Clinical characteristics of study population (n=80)

Clinical variables Mean ± standard deviation or n (%) Range
Race*
 Caucasian 77 (97.5)
 Non-Caucasian 2 (2.5)
Sex
 Male 53 (66.2)
 Female 27 (33.8)
Age, years 70 ± 8 (51 – 85)
Body mass index – kg/m2 28 ± 6 (18 – 58)
Smoker 50 (62.5)
Hypertension 61 (76.2)
Hyperlipidemia 71 (88.8)
Diabetes 9 (11.2)
Coronary artery disease 22 (27.5)
Peripheral artery disease 18 (22.5)
Antihypertensive use 63 (78.8)
Statin use 65 (81.2)
Antiplatelet use 64 (80.0)
Anticoagulant use 1 (1.2)
*

One subject was excluded due to a missing value for race.

HHS Vulnerability Disclosure